New player emerges in 23andMe bankruptcy An Indian drug company has big plans for the East Bay An Indian drug company has big ...

A twice-a-year shot to prevent HIV being dubbed a "wonder drug" by some could be coming to Canada as soon as next year, ...

Opinion, comment and editorials of the day ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The FDA recently approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued the ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The same tools that companies use to sell products can be used to encourage people to get vaccinated, get a colonoscopy or ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.